Invest now
RPG Life Sciences share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹2,705.00(-2.61%)September 11, 2026 15:22:19 PM IST
- NSE
- BSE
- Vol : 18.29 K (NSE + BSE)Last 20 day avg : 15.36 K
RPG Life Sciences is trading -2.61% lower at Rs 2,705.00 as compared to its last closing price. RPG Life Sciences has been trading in the price range of 2,738.00 & 2,691.00. RPG Life Sciences has given 19.83% in this year & 4.91% in the last 5 days. RPG Life Sciences has TTM P/E ratio 31.69 as compared to the sector P/E of 37.04.There are 1 analysts who have initiated coverage on RPG Life Sciences. There are 0.00 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 30.76 Crores in its last quarter.Listed peers of RPG Life Sciences include Sun Pharmaceutical Industries (-1.18%), Divi's Laboratories (-0.84%), Torrent Pharmaceuticals (0.95%).The Mutual Fund holding in RPG Life Sciences was at 0.04% in 30 Jun 2026. The MF holding has decreased from the last quarter. The FII holding in RPG Life Sciences was at 0.95% in 30 Jun 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 11 Sep 2026, 10:32 PM IST
- BetaMedium volatility1.02Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.03The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.86Annual dividends as a percentage of the stock price.
- P/BHigher than historical values7.60The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values38.47Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates Fair Valuation1.98The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
RPG Life Sciences News
RPG Life Sciences Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,842.00 | -1.18 | 4,41,947.09 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 9,326.00 | -0.84 | 2,47,576.00 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,975.00 | 0.95 | 1,89,226.24 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,365.00 | -1.09 | 1,10,272.68 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,119.50 | 0.13 | 1,11,670.56 | 21.19 | 4.24 | 0.09 | 14.22 |
Mutual Fund Ownership
View allRPG Life Sciences Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-07-28 | Quarterly Results |
| 2026-04-29 | Audited Results & Final Dividend |
| 2026-01-27 | Quarterly Results |
| 2025-10-17 | Quarterly Results |
| 2025-07-25 | Quarterly Results |
About the company RPG Life Sciences
- IndustryBiotechnology & Drugs
- ISININE105J01010
- BSE Code532983
- NSE CodeRPGLIFE
RPG Life Sciences Limited is an India-based research-based pharmaceutical company. The Company operates in the domestic and international markets in the formulations, generics, and synthetic active pharmaceutical ingredients (APIs) space. Its business portfolio includes domestic formulations, international formulations, and APIs. Its domestic formulation business manufactures and markets branded finished dosage formulations in India. The domestic formulations business has a presence in nephrology, oncology, rheumatology, cardiology, respiratory, pain management, vitamins & minerals, gastroenterology, and gynecology & pediatrics. The International Formulations business operates in the generics and branded generics space across Canada, Europe, Australia, New Zealand, and South America. Its products include Azoran, Mofetyl, Arpimune ME, Azathioprine, Quinfamide, Nicorandil, Haloperidol, Risperidone, Tolvaptan, Spironolactone, Sertraline, Naprosyn, Teristrong, and others.
RPG Life Sciences Share Price FAQs
RPG Life Sciences is trading at 2705.00 as on Fri Sep 11 2026 09:52:19. This is -2.61% lower as compared to its previous closing price of 2777.50.
The market capitalization of RPG Life Sciences is 4437.93 Cr as on Fri Sep 11 2026 09:52:19.
The average broker rating on RPG Life Sciences is Buy. The breakup of analyst rating is given below -
- 0.00 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for RPG Life Sciences is 3080.90 whereas the 52 wk low is 1731.25
RPG Life Sciences can be analyzed on the following key metrics -
- TTM P/E: 31.69
- Sector P/E: 37.04
- Dividend Yield: 0.86%
- D/E ratio: -
RPG Life Sciences reported a net profit of 115.17 Cr in 2026.
The Mutual Fund Shareholding was 0.04% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
RPG Life Sciences QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.